Paul Tomko

Big win at @IntuitiveMchns as @NASA awards our sixth CLPS task order (CS-8) for a 2028 mission support the Artemis Moon Base. IM is accelerating our mission execution from the historical 4+ year task order award to mission timeline, to just over two years, demonstrating our ability to rapidly scale production lander capability and support ops. The mission is clear. Faster cadence using proven systems to rapidly build out critical cislunar infrastructure. Team execution at its best. Ad Lunam 🚀 #Artemis #MoonBase #CLPS #IntuitiveMachines

It was a great evening at the @AFA_Air_Space @USSpaceForce 5th Annual Space Force Ball at the Beverly Hilton with the @Int_Machines team. Always a highlight reconnecting with old NRO colleagues and discussing how commercial space innovation can accelerate the USSF’s mission to secure our Nation’s interests in space. At IM, we’re delivering agile, FFP solutions across LEO, MEO, GEO, and cislunar domains, providing rapid comms, PNT, ISR, and space domain awareness capabilities. Excited to keep pushing the commercial edge forward with our Guardians.

Intuitive Machines is now the prime contractor for NASA’s LROC and the ShadowCam instrument. We’ll lead imaging ops, data analysis, and mission support, advancing real-time navigation and precision surface operations for future lunar missions. Exploration is empowered by data-driven insights. intuitivemachines.com/discover/news/…

@bryan_johnson How long did it take for your biomarkers (specifically fasting glucose, C-peptide, and REM) to normalize after stopping? And did you consider the no-DAC version (more pulsatile, shorter half-life) or a true GHRP/GHRH stack instead of solo DAC for better control?

People mistakenly believe peptides are only good. Peptides can be bad, too. They can cause adverse effects. Some dangerous. I did a peptide experiment and measured its effects in my body. The results are complicated. I tried a peptide called CJC-1295. It pushed my growth hormone up by ~8x. That’s good. That’s what it was supposed to do. But, it also came with adverse effects: > increased my morning fasted blood sugar up 20% > increased stress hormone by 12% > tanked my REM sleep by 23% > made my pancreas work 53% harder and was still losing to rising blood glucose > increased my insulin resistance by 50% These were the most obvious side effects, and I only ran a very narrow panel for this experiment. So I’m sure there’s more. I stopped after two doses, without even reaching the intended target dose. For those of you new to peptides, your body sends instructions to itself using tiny chemical messengers called peptides. There are thousands of them. For example, GLP-1s are drugs that take an existing class of short-lived peptides and modify them to extend their activity duration, which turns them into drugs, following rigorous clinical testing. CJC-1295 is one of those peptide-drugs. It tells your brain to release more growth hormone. Growth hormone is your body's signal to build muscle, repair tissue, and recover. However, and like most grey market peptides, CJC-1295 did not succeed its clinical trial, and hence never became an “official” drug. There is a version called CJC-1295 with DAC. DAC is an attachment glued onto the peptide that makes it last for days in your body instead of hours. One shot, longer effect, just like GLP-1s. Why people use it: more growth hormone could mean better recovery, leaner body, faster healing. The experiment I completed. Two injections a week of CJC-1295 with DAC: > 1.2 mg > 1.8 mg 48 hours after the first injection I was nearly comatose. It felt like severe jet lag, the type you’d feel after traveling nine time zones. My sleep was wrecked and I felt continuously awful. My REM sleep dropped by 23%. REM is when your brain processes memories and repairs itself. Less time for my brain to repair itself. During the experiment, I never felt rested and always fatigued. Why we chose CJC-1295 with DAC. Some will say we picked the wrong peptide. They will say I should have used a different version, CJC-1295 without DAC, mixed with another peptide called Ipamorelin. We went with CJC-1295 with DAC instead as it has the most controlled studies. CJC-1295 with DAC has 2 controlled trials in healthy adults. Ipamorelin alone has 1 controlled trial in healthy adults, plus 1 study that failed when they tried it on bowel surgery patients. The mix of the two has zero controlled trials. On Ipamorelin, it copies a chemical called ghrelin, the one that makes you hungry. On its own it gives you a quick burst of growth hormone that fades fast. It does not keep your longer acting growth signal (called IGF-1) up. Clinics mix Ipamorelin with CJC-1295 no-DAC because the two together are supposed to work better. But we don’t know if that’s accurate because we don’t have trial data. This is a problem with peptides. Almost none of them have been tested properly. We are flying blind. Most of what people use is based on what someone said online, what a clinic claims, or what a friend reports from their subjective feelings. Peptides have the potential to be great when well-studied.

Today marks another significant step forward as @NASA continues to expand commercial lunar capabilities through the CLPS program. @Int_Machines has been awarded the IM-5 task order, which will deploy our larger Nova-D-class lander to Mons Malapert at the lunar South Pole. This award unlocks substantially greater payload capacity and advanced payload hosting capabilities. This mission will carry seven payloads, including lunar rovers from the @AusSpaceAgency and Blue Origin's @HB_Robotics None of this would be possible without the relentless work behind the scenes by our world-class teams, continuously improving our lander design, flight systems, and surface operations through our steady cadence of missions. Thank you, @NASA_Johnson, for your ongoing trust. We are building the foundational infrastructure that will enable long-term science, mobility, and human exploration at the Moon and beyond. Ad Lunam!

Let’s go! 🚀 🌖

Exciting times ahead for @Int_Machines and our fellow American space companies that are committed to building out a sustained Moon base #adlunam

@Int_Machines is at the Lunar and Planetary Institute and @NASA_Johnson hosted Lunar and Planetary Science Conference (LPSC) through Thursday this week! Stop by our booth, the LRO/ShadowCam booth, and LTV to discuss science missions, lunar, space, and Martian technologies and applications. Learn about our new Build-Connect-Operate business framework and the enhanced satellite bus capabilities unlocked by our recent Lanteris Space Systems acquisition!

This is just the shake-up we needed. I’m hoping @rookisaacman is able to gather and maintain the sustained support he will need to see this transformation through. Bringing back the old NASA, I love it. Ad Lunam!

It’s like being in a sci-fi movie, but I’m staying cautiously optimistic for a good ending. As quickly as things are changing, one thing is for certain, it’s never been a more exciting time to be a fan of space or to work in space industry. Humanity will indeed live amongst the stars 🚀

And that’s (almost) a wrap on Day One. Today, President Trump signed a historic commitment to American leadership in space and @NASA along with our commercial and international partners will deliver. 🇺🇸🌖 The greatest adventure continues. 🚀

Congrats @rookisaacman 🇺🇸🚀
Looking forward to this next chapter for NASA and America’s space leadership!

Let’s go 🚀 @rookisaacman

I am really liking the energy and focus on the Moon--especially any endeavor that could unlock an orbital or lunar economy. We are never going to have the future we dream of w/numerous space stations and lots of people working and traveling in space, if it all depends exclusively on taxpayer funding. I know the near-term won’t be easy, especially with the shutdown impacting so many across NASA and the government, but we are living in an incredible time... multiple launch providers driving reusability to lower cost to orbit, important dev programs like on-orbit refueling to extend reach, and private capital betting on everything from pharmaceutical formulations to asteroid mining and orbital computing. Once we crack the economic code, we will have the answer (and funding) as to why we need lots of people living and working in space.

@daveginvesting @ashleevance 😂

@TomkoSpace @ashleevance Well, personally I have to say I am in favour of not dying... Guess I better start taking Viagra 😄

We already learned about the biological age of Brian Johnson's rectum from @ashleevance, but apparently that wasn't enough so now we are also learning about his nighttime erections...

@richellellisart @thesheetztweetz Congrats @richellellisart !

My Artwork Now Rests on the Moon ✨🌙 On March 2, 2025, Firefly Aerospace’s Blue Ghost successfully landed in Mare Crisium near Mons Latreille at 12:45 a.m. PST (8:45 UTC). Congratulations to Firefly Aerospace on this remarkable achievement! I am deeply honored and grateful to Ben Haldeman (LifeShip) for this extraordinary opportunity. Through his vision and dedication, my Biospheres and Trees of Life drawings are now preserved on the lunar surface, part of a mission designed to endure for over a billion years. This marks the second of several missions carrying my work to the Moon—and soon, into deep space. It is an incredible privilege to contribute to this historic endeavor. Thank you. 🙏 #FireflyAerospace #LifeShip #ArtOnTheMoon #GhostRiders #NASA #ArtistsOnTheMoon #Biodiversity #Drawings #Paintings #Gratitude

@daveginvesting @fireflyspace Also a great win for @RocketLab as they continue to deepen their operational experience across numerous space domains, LEO, cislunar, LEO Earth return, and now lunar landing. With Venus next!

Amazing! Congratulations to @fireflyspace on this historic achievement! First attempt too!

Congrats to the whole @fireflyspace team on their first lunar landing. There are now two American commercial lunar landers on the moon, both from Texas, with the next landing later this week with the @Int_Machines IM-2 mission. What a time to be alive and working in the U.S. space industry. Congrats also to the NASA CLPS team for their incredible support to make these missions happen and bring humanity back to the moon, this time to stay.

RT @Int_Machines: Athena completed her second planned Trajectory Correction Maneuver (TCM) at 11:00 a.m. CT on March 1, to refine the lande…